Skip to content

Association between familial patent foramen ovale and epilepsy

Association between familial patent foramen ovale and epilepsy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200062419
Enrollment
Unknown
Registered
2022-08-05
Start date
2022-08-01
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PFO and Epilepsy

Interventions

Healthy control group:None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Epilepsy group (1) Age 3-65 years old, gender unlimited; (2) The diagnosis of epilepsy conforms to the diagnostic criteria of epilepsy in the Chinese epilepsy clinical diagnosis and treatment guidelines (2015 Revision); (3) No previous history of serious heart disease; (4) The nervous system is normal. 2. Control group (1) Age 3-65 years old, gender unlimited (female non pregnancy); (2) No history of headache, sleep apnea, stroke; (3) No previous history of serious heart disease; (4)The nervous system is normal.

Exclusion criteria

Exclusion criteria: 1. Patients who are unwilling to accept data registration or transthoracic echocardiography contrast echocardiography; 2. Unable to cooperate with the completion of Valsalva mover; 3. Other congenital heart diseases (such as atrial septal defect, ventricular septal defect, etc.) were found by transthoracic echocardiography.

Design outcomes

Primary

MeasureTime frame
Genomics;

Countries

China

Contacts

Public ContactLei Chen

West China Hospital, Sichuan University

leilei_25@126.com+86 18980605819

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026